Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD 0.1150
+0.0010 (0.88%)
At close: Feb 13, 2026
Uni-Bio Science Group Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 91.35 | 82.77 | 70.88 | 38.51 | -19.59 | -71.32 |
Depreciation & Amortization | 19.13 | 17.35 | 16.44 | 17.09 | 20.37 | 20.92 |
Other Amortization | 4.01 | 4.01 | 0.44 | 0.46 | 0.48 | - |
Loss (Gain) From Sale of Assets | 0.57 | 0.57 | 0.61 | 0.76 | 2.63 | 0.39 |
Asset Writedown & Restructuring Costs | - | - | - | - | -0 | 33.96 |
Loss (Gain) From Sale of Investments | -0.13 | -0.13 | - | - | -0.04 | -0.95 |
Stock-Based Compensation | 0.18 | 0.18 | - | 0.54 | 3.93 | 10.89 |
Provision & Write-off of Bad Debts | 5.48 | 5.48 | 1.1 | 2.27 | -1.94 | 1.31 |
Other Operating Activities | 3.83 | 9.97 | 0.3 | 0.33 | 12.19 | -1.11 |
Change in Accounts Receivable | -27.01 | -27.01 | -1.07 | 0.82 | 14.46 | -12.91 |
Change in Inventory | -3.29 | -3.29 | -4.39 | 2.08 | -23.19 | -3.18 |
Change in Accounts Payable | -16.39 | -16.39 | 11.52 | -13.91 | -4.28 | 12.99 |
Change in Unearned Revenue | -6.8 | -6.8 | 3.02 | -0.3 | 7.03 | -6.47 |
Operating Cash Flow | 70.93 | 66.71 | 98.85 | 48.66 | 12.04 | -15.47 |
Operating Cash Flow Growth | -42.12% | -32.52% | 103.14% | 304.09% | - | - |
Capital Expenditures | -38 | -38 | -59.74 | -28.43 | -8.43 | -3.44 |
Sale of Property, Plant & Equipment | 0.14 | 0.14 | - | 0.1 | 0.02 | 0.06 |
Sale (Purchase) of Intangibles | - | - | - | - | - | -9.54 |
Investment in Securities | -114.75 | -114.75 | - | - | 36.36 | -12.23 |
Other Investing Activities | 106.99 | -15.46 | -16.41 | 1.3 | 14.18 | 0.5 |
Investing Cash Flow | -45.62 | -168.07 | -76.14 | -27.03 | 42.12 | -24.65 |
Short-Term Debt Issued | - | 5.13 | 7.21 | 15.24 | 7.64 | - |
Long-Term Debt Issued | - | 70.4 | 41.88 | - | - | - |
Total Debt Issued | 75.54 | 75.54 | 49.09 | 15.24 | 7.64 | - |
Short-Term Debt Repaid | - | -6.72 | -3.59 | - | - | - |
Long-Term Debt Repaid | - | -15.01 | -15.04 | -3.83 | -0.68 | -0.35 |
Total Debt Repaid | -21.73 | -21.73 | -18.63 | -3.83 | -0.68 | -0.35 |
Net Debt Issued (Repaid) | 53.81 | 53.81 | 30.46 | 11.41 | 6.97 | -0.35 |
Repurchase of Common Stock | -24.83 | -24.83 | -5.17 | - | -6.01 | -4.98 |
Other Financing Activities | -55.58 | -1.19 | -0.78 | -8.83 | -0.48 | -0.07 |
Financing Cash Flow | -26.6 | 27.79 | 24.51 | 2.58 | 0.48 | -5.41 |
Foreign Exchange Rate Adjustments | 17.84 | 9.34 | -16.2 | -9.6 | 3.96 | 4.34 |
Net Cash Flow | 16.55 | -64.23 | 31.02 | 14.61 | 58.6 | -41.19 |
Free Cash Flow | 32.93 | 28.71 | 39.11 | 20.23 | 3.61 | -18.91 |
Free Cash Flow Growth | -47.57% | -26.59% | 93.33% | 460.70% | - | - |
Free Cash Flow Margin | 5.58% | 5.19% | 8.07% | 4.59% | 1.02% | -9.06% |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | -0.00 |
Cash Interest Paid | 1.19 | 1.19 | 0.78 | 0.38 | 0.48 | 0.07 |
Cash Income Tax Paid | 6.46 | 6.46 | 8.94 | 3.62 | 1.43 | 0.83 |
Levered Free Cash Flow | -1.84 | -13.81 | 18.17 | 25.8 | 34.81 | -5.41 |
Unlevered Free Cash Flow | -0.79 | -13.07 | 18.66 | 26.04 | 35.11 | -5.36 |
Change in Working Capital | -53.48 | -53.48 | 9.08 | -11.3 | -5.99 | -9.57 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.